RESEARCH TRIANGLE PARK, NC – Paul Ulanch, executive director of Biotechnology Crop Commercialization at the North Carolina Biotechnology Center, says an announcement that Bayer CropScience is pumping $33 million more into its Research Triangle Park campus isn’t just good news for CEO Jim Blome and company. It’s further validation of RTP’s solidifying status as ground zero for agribiotech in the United States.
And that’s not the only good news RTP will see coming out of the plant science industry.
Bayer CropScience’s move, Ulanch says, is “to prepare for future expansion.” And it’s a pattern he sees with Syngenta and BASF. He’s hoping some day to have another big player in the park.
The big name that’s missing from the current roster? Dow AgroSciences.
So I asked Ulanch whether conversations have been happening with the chemical giant.
“We talk to them every now and then,” he says, adding that most of the conversations are about the potential to collaborate with university research projects. “It’s more or less a conversation about what opportunities lie in North Carolina and, if there’s ever an opportunity that interests them, we’d like to help them accelerate that.”
North Carolina’s doors are “wide open” for Dow Agro, if and when they’d like to walk through.